January 7, 2013
San Francisco, California
March 11, 2013
Barcelona, Spain
March 19, 2013
10:30 AM PDT
Dana Point, California
April 22, 2013
Chicago, Illinois
May 12, 2013
04:10 PM EDT
Tel-Aviv, Israel
Speaker(s):
-
Ori Shilo , Deputy CEO, Finance & Operations
June 3, 2013
10:30 AM EDT
The Grand Hyatt Hotel, New York City
Speaker(s):
-
Guy Goldberg, Chief Business Officer
June 10, 2013
Tel-Aviv, Israel
Israel
July 10, 2013
St. Regis Hotel, New-York
New-York, AL
United States
RedHill presentation will take place July 10th at 12:00 p.m. EDT
September 17, 2013
Boston, MA, USA
October 28, 2013
The Ritz Carlton, Laguna Niguel, CA
RedHill presentation will take place on Monday, October 28, 2013, at 12:15 p.m. EDT
November 4, 2013
Vienna, Austria
RedHill's presentation will take place on Tuesday, November 5, 2013, at 8:45 a.m.
CET at the Messe Wien Exhibition and Congress Center in Vienna, Austria
November 7, 2013
Dan Tel-Aviv Hotel
Israel
Speaker(s):
-
Guest of Honor, Prof. Thomas Borody, MD.
An internationally renowned expert in the field of gastroenterology and inventor of therapeutic candidates, RHB-104 for Crohn's disease and RHB-105 for the treatment of H. pylori
RedHill Biopharma will presnet its recent clinical developments and business updates.
Registration is required, the number of participants is limited.
In order to register for please contact Merav Shiryan, no later than Oct. 15th.
January 13, 2014
Parc 55 Wyndham Hotel San Francisco – Union Square
San Francisco, CA 94102
United States
January 13, 2014
San Francisco, CA
AL
United States
March 9, 2014
The Ritz-Carlton, Dana Point
CA
United States
March 10, 2014
Turin, Italy
Israel
May 1, 2014
08:30 AM EDT
Tel-Aviv Stock Exchange
Israel
RedHill will be the second in order to present at the conference. For more information on the conference please contact:
Eran Gabay - VP and Managing Director, Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
+972 (0)3 6070 597
erang@gk-biz.com
May 7, 2014
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
May 11, 2014
David Intercontinental Hotel
Tel-Aviv
Israel
Speaker(s):
-
Guy Goldberg, Chief Business Officer
June 5, 2014
The Grand Hyatt, New York City
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill will present on Thursday, June 5, 2014, at 13:30 EDT in Ballroom 2
June 17, 2014
The InterContinental Boston - Boston, MA
Speaker(s):
-
Guy Goldberg, Chief Business Officer
June 23, 2014
San Diego, CA
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill will present on Thursday, May 26th at 10:45 am, at the Mission Beach room
June 23, 2014
The Dorchester Hotel - London, UK
June 24, 2014
The Carlton Hotel, Tel-Aviv
September 4, 2014
08:30 AM EDT
Hilton Tel-Aviv
For more information on the conference please contact:
Eran Gabay - VP and Managing Director, Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
+972 (0)3 6070 597
erang@gk-biz.com
September 8, 2014
New-York Palace Hotel, NYC
Speaker(s):
-
Dror Ben-Asher, RedHill CEO
RedHill will present on Wendsday, September 10th, at 1:40 pm (ET), at the Holmes II Salon (4th floor)
September 22, 2014
Boston, MA, USA
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill will present on Tuesday, September 23rd, at 2:45 pm (ET), at the Suffolk room (level 3).
September 30, 2014
Congress Center Basel, Switzerland
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill will present on September 30th at 12:00 p.m. in the Darwin room.
RedHill will also take part in the Israel Panel which will take place September 30th at 14:45 p.m.
November 3, 2014
Portalhaus Messe Frankfurt, Germany
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill will present on November 4, at 10:00 am in the Transparenz room (Level 1).
November 24, 2014
Dan Hotel Tel-Aviv, Israel
RedHill is a Silver Sponsor of the Israeli IBD Society Meeting and will take part in the conference.
December 10, 2014
08:30 AM EST
Tel-Aviv Stock Exchange, Ahuzat Bayit St. 4, Isreal
RedHill will be the second in order to present at the conference.
For more information on the conference please contact:
Eran Gabay - VP and Managing Director, Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
+972 (0)3 6070 597
erang@gk-biz.com
November 2, 2015
Munich, Germany
Speaker(s):
-
Adi Frish, Senior VP Business Development & Licensing
RedHill's presentation will be held on Tuesday, November 3, 2015 at 10:45 am
November 18, 2015
02:40 AM UTC
The May Fair Hotel, Stratton Street, London
January 19, 2016
08:30 AM IST
Tel-Aviv Stock Exchange, Israel
To participate in the conference please contact Gelbat-Kahana by email at: erang@gk-biz.com, or by telephone: +972-(0)3-6070-591.
February 8, 2016
Waldorf Astoria, New York
RedHill will present on Tuesday, Feb.. 9th, at 4:00 pm, at the Park North room.
March 4, 2016
Stockholm, Sweden
Speaker(s):
-
Adi Frish, SVP Business Development & Licensing
RedHill's presentation will be held on Tuesday, March 5, at 10:00 am.
March 13, 2016
Orange County
CA
United States
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill's presentation will be held on Tuesday, March 15, 2016, at 8:30 am PT
April 5, 2016
Stockholm, Sweden
Speaker(s):
-
Adi Frish, Senior VP Business Development & Licensing
RedHill's presentation will be held on Tuesday, April 5th, at 10:00 am
April 20, 2016
08:30 AM
J.W. Marriott Essex House, New York City
Dr. Fathi will participate in a panel discussion entitled “The Human Microbiome and Applications in Novel Therapeutics”
May 2, 2016
Orlando, FL
Speaker(s):
-
Adi Frish, SVP Business Development & Licensing
June 8, 2016
RedHill Biopharma Offices
Tel-Aviv
Israel
Notice is hereby given that the annual general meeting of shareholders of the Company will be held on Wednesday, June 8th, 2016 at 3:00 p.m. Israel time, at the Company’s offices located at 21 Ha'arba'a Street, Floor 16, Tel Aviv.
Please see attached file for the meeting agenda.
רדהיל מודיעה בזאת על זימונה של אסיפה כללית שנתית של בעלי המניות בחברה שתתקיים ביום
רביעי, 8 ביוני 2016, בשעה 15:00 (שעון ישראל) במשרדי החברה אשר ברחוב הארבעה 21, קומה 16,
תל אביב (טל': 03-5413131).
ראה מסמך מצורף בנוגע לסדר היום של האסיפה.
June 21, 2016
NYC
Mr. Ben-Asher will present on Wednesday, June 21, at 10:30 am EDT.
July 26, 2016
09:00 AM EDT
RedHill will host a conference call on Tuesday, July 26, 2016, at 9:00 am EDT (4:00 pm Israel) to review the financial results and business highlights.
To participate in the conference call, please dial the following numbers five to ten minutes prior to the start of the call: United States: + +1-877-280-1254; International: + 1-646-254-3388; and Israel: +972-3-763-0147. The access code for the call is 539724.
The conference call will be broadcasted live and available for replay on the Company's website for 30 days. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software.
September 12, 2016
03:00 PM EDT
The Lotte New York Palace Hotel, New York
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill Biopharma's presentation:
Date: 12 Sep 2016
Time: 3:00:00 PM
Room: Holmes I (4th Floor)
September 14, 2016
03:00 PM EDT
Boston Marriott Copley Place, Boston, MA
Speaker(s):
-
Adi Frish, SVP Business Development & Licensing
RedHill Biopharma's presentation:
Date: 14 Sep 2016
Time: 3:00:00 PM
Room: Salon D, Level 4
October 5, 2016
The Ritz-Carlton, Laguna Niguel, CA
Speaker(s):
-
Adi Frish, Senior VP Business Development & Licensing
RedHill Biopharma's presentation:
Date: Thursday, 6 Oct 2016
Time: 9:15 AM
Room: Ballroom, Salon 3
October 6, 2016
08:30 AM EDT
RedHill will hosted an interactive webcast and conference call on Thursday October 6th, 2016, at 8:30 a.m. EDT, to discuss the progress update on the RHB-104 Phase III Crohn’s disease program.
The webcast and accompanying presentation will be archived and available for replay on the Company's website for 30 days.
October 18, 2016
10:30 AM PDT
Westin St. Francis Hotel, San Francisco, CA
RedHill Biopharma's presentation:
Date: Tuesday, 18 Oct 2016
Time: 10:30 AM
Room: Elizabethan A
November 7, 2016
KoelnMesse - Congress Center North, Cologne, Germany
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
Date: Wednesday, 9 Nov 2016
Time: 11:15 AM
Room: Rheinsaal 4
November 14, 2016
09:00 AM EST
RedHill will host a conference call on Monday, November 14, 2016, at 9:00 am EST (4:00 pm Israel) to review the financial results and business highlights.
To participate in the conference call, please dial the following numbers 5-10 minutes prior to the start of the call: United States: +1-877-280-2342; International: +1-646-254-3367; and Israel: +972-3-721-9510. The access code for the call is 2341628.
The conference call will be broadcasted live and available for replay on the Company's website, http://ir.redhillbio.com/events.cfm, for 30 days. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software.
November 17, 2016
02:40 PM UTC
London, UK
RedHill Biopharma's presentation:
Date: 17 Nov 2016
Time: 14:40:00 PM
November 21, 2016
12:00 PM CET
Sheraton Frankfurt Airport Hotel and Conference Center, Frankfurt am Main, Germany
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill Biopharma's presentation:
Date: Monday, 21 Nov 2016
Time: 12:00 pm
Room: Oslo
December 7, 2016
09:30 AM EST
Tel-Aviv Stock Exchange, Israel
To participate in the conference please contact Gelbat-Kahana by email at: info@gk-biz.com, or by telephone: +972-(0)3-6074-717.
RedHill Biopharma's presentation will take place at 9:30 AM.
January 4, 2017
Speaker(s):
-
Ira Kalfus, Medical Director
January 9, 2017
Westin St. Francis Hotel, San Francisco, CA
January 9, 2017
Hilton San Francisco Union Square, San Francisco, CA
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill Biopharma's presentation:
Date: Tuesday, 10 Jan 2017
Time: 09:30 AM
Room: 3 (Ballroom Level)
February 13, 2017
The Waldorf Astoria, New York
RedHill Biopharma's presentation:
Date: Monday, 13 Feb 2017
Time: 03:30 PM
Room: Conrad
February 23, 2017
09:00 AM EST
RedHill will host a conference call on Thursday, February 23, 2017, at 9:00 am EST (4:00 pm Israel) to review the financial results and business highlights.
To participate in the conference call, please dial the following numbers 5-10 minutes prior to the start of the call: United States: +1-877-280-1254; International: +1-646-254-3366; and Israel: +972-3-763-0145. The access code for the call is 4402478.
The conference call will be broadcasted live and available for replay on the Company's website, http://ir.redhillbio.com/events.cfm, for 30 days. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software.
March 20, 2017
Barcelona, Spain
Speaker(s):
-
Adi Frish, SVP Business Development & Licensing
RedHill Biopharma's presentation:
Date: Tuesday, 21 March 2017
Time: 2:15 PM
Room: 118 on level 1
March 25, 2017
Temple University, Philadelphia, PA
Speaker(s):
-
Ira Kalfus, MD, Medical Director
RedHill Biopharma's presentation:
Date: Saturday, 25 March 2017
Time: 9:00 AM
April 7, 2017
New York City
RedHill Biopharma's presentation:
Date: Friday, 7 April 2017
Time: 9:00 AM
Room: 311
April 27, 2017
08:00 AM
NYC
Members of RedHill’s executive team will be joined by key opinion leaders who will discuss BEKINDA®, its indications, the current treatment landscape, potential markets and the ongoing Phase III and II studies for acute gastroenteritis and IBS-D, respectively. A question and answer panel will be held following the presentations.
A live webcast of the event, including the slide presentation, will be available vie the below link. Please access the webcast at least 15 minutes ahead of the conference to register, download, and install any necessary audio software. A replay of the webcast will be available via the below link for a period of 30 days.
Featured Key Opinion Leaders:
Robert A. Silverman, MD, MS
Lead Investigator, BEKINDA® Phase III Study
Emergency Medicine specialist at the Hofstra North Shore-LIJ Medical Center, Associate Professor at the Hofstra North Shore-LIJ School of Medicine in NY
M. Scott Harris, MD, MS, FACP, AGAF
Consultant to RedHill Biopharma
Member of the Executive Board of the Center for Diagnostics and Therapeutics of the American Gastroenterological Association, Professor of Clinical Pharmacology and Physiology at Georgetown University School, Principal, Middleburg Consultants
Jerry Rosenblatt, PhD
RedHill Biopharma Advisory Board
Managing Partner, Foster Rosenblatt
May 3, 2017
RedHill will host a conference call on Wednesday, May 3, 2017, at 9:00 am EDT to review the financial results and business highlights.
To participate in the conference call, please dial the following numbers 15 minutes prior to the start of the call: United States: +1-877-280-2342; International: +1-212-444-0896; and Israel: +972-3-763-0147. The access code for the call is 1922788.
The conference call will be broadcasted live and available for replay on the Company's website, http://ir.redhillbio.com/events.cfm, for 30 days. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software.
May 7, 2017
Tel Aviv, Israel
For registration please email: info@gk-biz.com
May 11, 2017
RedHill Biopharma Offices
Notice is hereby given that the annual general meeting of shareholders of the Company will be held on Thursday, May 11, 2017 at 3:00 p.m. Israel time, at the Company’s offices located at 21 Ha'arba'a Street, Floor 16, Tel Aviv.
Please see attached file for the meeting agenda.
June 19, 2017
San Diego Convention Center, San Diego, CA
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill Biopharma's presentation:
Date: Tuesday, 20 June 2017
Time: 04:15 PM
Room: Therater 3
June 21, 2017
08:30 AM EDT
Tel-Aviv Stock Exchange, Israel
To participate in the conference please contact Gelbat-Kahana by email at: info@gk-biz.com, or by telephone: +972-(0)3-6074-717.
RedHill Biopharma's presentation will take place at 10:30 AM.
September 10, 2017
The Lotte New York Palace, NY
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill Biopharma's presentation:
Date: Tuesday, 12 September 2017
Time: 09:10 AM
Room: Louis
September 10, 2017
The Lotte New York Palace, NY
RedHill Biopharma's presentation:
Date: Tuesday, 12 September 2017
Time: 09:10 AM
Room: Louis
Contact:
info@redhillbio.com
+972-3-541-3131
September 25, 2017
InterContinental New York Barclay Hotel, NY
RedHill Biopharma's presentation:
Date: Tuesday, 26 September 2017
Time: 09:45 AM
Room: Grand Ballroom 1
September 26, 2017
Sheraton Boston Hotel, Boston, MA
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill Biopharma's presentation:
Date: Tuesday, 26 September 2017
Time: 11:45 AM
Room: Republic A, Level 2
October 18, 2017
08:00 AM EDT
Tel Aviv Stock Exchange, Israel
To participate in the conference please contact Gelbat-Kahana by email at: info@gk-biz.com, or by telephone: +972-(0)3-6074-717.
October 23, 2017
Ritz Carlton, Laguna Niguel, CA
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill Biopharma's presentation:
Date: Monday, 23 October 2017
Time: 12:20 PM
November 6, 2017
Berlin
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill Biopharma's presentation:
Date: Wednesday, 8 November 2017
Time: 12:15 PM
Room: M3, Level 3
November 13, 2017
09:00 AM EST
November 27, 2017
Sheraton Frankfurt Airport Hotel & Conference Center, Frankfurt
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill Biopharma's presentation:
Date: Tuesday, 28 November 2017
Time: 11:00 AM
Room: Oslo
Contact:
info@redhillbio.com
+972-3-5413131
January 8, 2018
Hilton San Francisco Union Square, San Francisco, CA
February 12, 2018
New York Marriott Marquis, NY
RedHill Biopharma's presentation:
Date: Monday, 12 February 2018
Time: 10:45 AM
Room: Ziegfeld
March 11, 2018
The Ritz-Carlton in Orange County, CA
Speaker(s):
-
Guy Goldberg, Chief Business Officer
March 11, 2018
The Ritz-Carlton in Orange County, CA
Speaker(s):
-
Guy Goldberg, Chief Business Officer
March 12, 2018
Amsterdam RAI Convention Center, Amsterdam, Netherlands
April 8, 2018
Le Meridien Beach Plaza Hotel, Monte Carlo, Monaco
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill Biopharma's presentation:
Date: Monday, 9 April 2018
Time: 11:05 AM
Room: Salon Atlantique
May 2, 2018
03:00 PM IDT
RedHill Biopharma Offices
The Annual General Meeting of Shareholders of RedHill Biopharma Ltd. will be held at the offices of the Company, 21 Ha'arba'a Street, Floor 16, Tel-Aviv, Israel on May 2, 2018 at 3:00 p.m. Israel time. Please see attached file for the agenda and Proxy Statement.
Contact Name: D.F. King
Contact Email: mhorthman@dfking.com
Contact Phone: T: +1-212-232-3233
May 8, 2018
To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call:
United States: +1-800-289-0438
International: +1-929-477-0353
Israel: +972-3-376-1315
Access code: 6285484
May 15, 2018
08:00 AM EDT
August 30, 2018
08:30 AM EDT
To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call: United States: +1-800-263-0877; International: +1-646-828-8143; and Israel: +972-3-721-9463. The access code for the call is: 9460445.
The conference call will be broadcast live and will be available for replay on the Company's website, http://ir.redhillbio.com/events, for 30 days. Please access the Company's website at least 15 minutes ahead of the conference call to register, download and install any necessary audio software.
September 4, 2018
The St. Regis New York
October 2, 2018
Sofitel Hotel, New York City
RedHill Biopharma's presentation:
Date: Tuesday, October 2, 2018
Time: 10:30 AM
Room: Track 5 - Montmartre
October 10, 2018
The Ritz-Carlton Laguna Niguel, CA
October 22, 2018
Vienna, Austria
An abstract discussing the study’s top-line results, ‘A Phase III Randomized, Double Blind, Placebo-Controlled, Multicenter, Parallel Group Study To Assess The Efficacy And Safety Of Add-On Fixed-Dose Anti-Mycobacterial Therapy (RHB-104) In Moderately To Severely Active Crohn's Disease (MAP US)’ was presented as a late-breaking abstract today at the United European Gastroenterology Week (UEG Week 2018) by Dr. David Y. Graham, M.D., Professor of Medicine, Molecular Virology and Microbiology at Baylor College of Medicine, Houston and Lead Investigator of the MAP US study.
October 30, 2018
08:30 AM EDT
Members of RedHill’s executive team will be joined by the study’s lead investigator and key opinion leader, Professor David Y. Graham, M.D., M.A.C.G., and will discuss TALICIA®, the ERADICATE Hp2 study, H. pylori infection, the current treatment landscape and potential market. A question and answer session will be held following the presentations.
Participants who wish to ask questions during the event can do so by dialing in to the event. To participate in the conference call, please dial one of the following numbers 5-10 minutes prior to the start of the call: United States: +1-800-458-4121; International: +1-929-477-0324; and Israel: +972-3-376-1315. The access code for the call is: 5774327.
November 5, 2018
Bella Center, Copenhagen, Denmark
Speaker(s):
-
Adi Frish, Chief Corporate & Business Development Officer
RedHill's presentation:
Date: Tuesday, Nov 6, 2018
Time: 16:15 CET
Room: B3 on level 0
Category: Gastrointestinal
November 13, 2018
08:30 AM EST
December 3, 2018
08:30 AM EST
December 12, 2018
Mandarin Oriental, New York
RedHill's presentation:
Date: Wednesday, Dec 12, 2018
Time: 3:00 PM ET
Room: NORTH SALON I
February 11, 2019
New York Marriott Marquis
February 26, 2019
08:30 AM EST
February 27, 2019
Lotte New York Palace, NY
March 17, 2019
Ritz-Carlton, Laguna Niguel, Dana Point, CA
Speaker(s):
-
Adi Frish, Chief Corporate & Business Development Officer
March 25, 2019
Messe Wien Exhibition and Congress Center, Vienna, Austria
Speaker(s):
-
Adi Frish, Chief Corporate & Business Development Officer
RedHill's presentation:
Date: Wednesday, March 27, 2019
Time: 9:45 CET
Room: Schubert 6 on level 1
Category: Gastrointestinal
April 7, 2019
JW Marriott Grosvenor House, London, UK
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill's presentation:
Date: Tuesday, April 9, 2019
Time: 11:30 a.m. GMT
Room: Spencer suite
April 10, 2019
Gaylord National Harbor Hotel, Oxon Hill, MD
Speaker(s):
-
Patricia Anderson, VP, Regulatory Affairs
RedHill's presentation:
Date: Friday, April 12, 2019
Time: 3:10 p.m. EDT
April 12, 2019
Millennium Broadway Hotel & Conference Center, NY
RedHill's Presentation:
Date: Friday, April 12, 2019
Time: 9:00:00 - 9:25 a.m. EST
Presentation Location: Room 402/403
May 7, 2019
08:30 AM EDT
Please dial one of the following numbers 15 minutes prior to the start of the call:
United States: +1-866-966-1396
International: +1-631-510-7495
Israel: +972-3-721-7998
Access code: 1777567
The conference call will be broadcast live and will be available for replay for 30 days.
June 3, 2019
Pennsylvania Convention Center, Philadelphia, PA
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill's Presentation:
Date: Monday, June 3, 2019
Time: 1:30:00 - 1:45 p.m. EST
Presentation Location: Theater 2
June 24, 2019
03:00 PM IDT
RedHill Biopharma Offices, 21 Ha'arba'a Street, Floor 16, Tel-Aviv, Israel
Please see attached file for the agenda and Proxy Statement.
Contact Name: Kingsdale Advisors
Contact Email: contactus@kingsdaleadvisors.com
Contact Phone USA: (888) 564-7333
Contact Phone Intl: +1-416-867-2272
July 23, 2019
08:30 AM EDT
Replay will be available for 30 days
September 5, 2019
Innsbruck, Austria
September 9, 2019
Lotte New York Palace Hotel, NY
RedHill's presentation:
Date: Monday, September 9, 2019
Time: 11:40 AM ET
Room: Adams (4th floor)
September 24, 2019
Sofitel Hotel, NY
Speaker(s):
-
Guy Goldberg, Chief Business Officer
RedHill's presentation:
Date: Tuesday, September 24, 2019
Time: 1:00 PM ET
Room: Trocadero (Track 1)
October 23, 2019
The Ritz-Carlton Laguna Niguel, CA
October 25, 2019
Henry B. Gonzlaez Convention Center, San Antonio Texas
November 11, 2019
Hamburg, Germany
Speaker(s):
-
Adi Frish, Senior VP Business Development and Licensing
RedHill's presentation:
Date: Tuesday, November 12, 2019
Time: 14:30 PM
Room: Hall B1 (Level 1, room 7)
November 19, 2019
08:30 AM EST
November 22, 2019
New York
The event featured presentations from RedHill's management team who provided an overview of the Company's U.S. commercial strategy for launching Talicia® and Aemcolo®. RedHill’s expects to launch Aemcolo® in Q4/19 and Talicia® in Q1/20 with its expanding dedicated sales force.
For further information please contact: investors@redhillbio.com
February 26, 2020
The Lotte New York Palace, NY
March 4, 2020
08:30 AM EST
March 15, 2020
The Ritz-Carlton Hotel, Laguna Niguel, CA
March 23, 2020
Paris, France
Speaker(s):
-
Adi Frish, Chief Corporate & Business Development Officer
RedHill's presentation:
Date: Tuesday, March 24, 2020
Time: 11:15 AM
Room: E04
March 26, 2020
09:30 AM EDT
Speaker(s):
-
Guy Goldberg, Chief Business Officer
April 19, 2020
JW Marriot Hotel, London, UK
Speaker(s):
-
Guy Goldberg, Chief Business Officer
May 4, 2020
03:00 PM IDT
RedHill Biopharma Offices, 21 Ha'arba'a Street, Floor 16, Tel-Aviv, Israel
Please see attached file for the proxy statement.
Contact Name: Kingsdale Advisors
Contact Email: contactus@kingsdaleadvisors.com
Contact Phone USA: +1-866-581-1392
Contact Phone Intl: +1-416-867-2272
May 18, 2020
RedHill's Virtual Presentation:
Date: Monday, May 18, 2020
Time: 7:30 AM ET
May 19, 2020
Speaker(s):
-
Gilead Raday, Chief Operating Officer
May 27, 2020
08:30 AM EDT
June 8, 2020
Speaker(s):
-
Adi Frish, Chief Corporate & Business Development Officer
June 15, 2020
Speaker(s):
-
Gilead Raday, Chief Operating Officer
RedHill's Virtual Presentation:
Date: Monday, June 15, 2020
Time: 12:40 PM ET
June 25, 2020
10:00 AM EDT
Speaker(s):
-
Guy Goldberg, Chief Business Officer
July 7, 2020
Speaker(s):
-
Gilead Raday, Chief Operating Officer
Panel participation:
Topic: Potential Therapeutic Strategies to Prevent and Conquer Covid-19 Panel
Date: Wednesday, July 8, 2020
Time: 10:15 a.m. EDT/4:15 p.m. CET
August 3, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
August 12, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
August 13, 2020
08:30 AM EDT
September 3, 2020
08:40 AM EDT
Speaker(s):
-
Guy Goldberg, Chief Business Officer
September 10, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
September 10, 2020
11:40 AM EDT
September 14, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
September 15, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
September 17, 2020
08:45 AM EDT
September 21, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
October 13, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
October 26, 2020
Speaker(s):
-
Adi Frish, Chief Corporate & Business Development Officer
October 28, 2020
Speaker(s):
-
Gilead Raday, Chief Operating Officer
October 29, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
November 16, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
December 1, 2020
Speaker(s):
-
Guy Goldberg, Chief Business Officer
January 11, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
January 26, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
February 16, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
March 8, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
March 9, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
March 15, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
March 18, 2021
08:30 AM EDT
March 22, 2021
Speaker(s):
-
Adi Frish, Chief Corporate & Business Development Officer
May 6, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
May 14, 2021
09:50 AM EDT
May 27, 2021
08:30 AM EDT
June 1, 2021
08:30 AM EDT
Speaker(s):
-
Guy Goldberg, Chief Business Officer
June 14, 2021
Speaker(s):
-
Adi Frish, Chief Corporate & Business Development Officer
July 26, 2021
03:00 PM IDT
RedHill Biopharma Offices, 21 Ha'arba'a Street, Floor 16, Tel-Aviv, Israel
August 26, 2021
08:30 AM EDT
September 13, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
Presentation to be available from Sep. 13th, 7 am ET.
September 30, 2021
08:40 AM ET
Speaker(s):
-
Guy Goldberg, Chief Business Officer
Conference Dates: September 27 - September 30, 2021
Fireside chat:
Date: Thursday, September 30, 2021
Time: 8:40 AM EDT
September 30, 2021
09:30 AM ET
Speaker(s):
-
Guy Goldberg, Chief Business Officer
October 5, 2021
Speaker(s):
-
Guy Goldberg, Chief Business Officer
October 7, 2021
08:30 AM ET
To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call:
United States: +1-877-870-9135; International: +1 646-741-3167 and Israel: +972-3-530-8845; the access code for the call is: 4785122.
October 25, 2021
Speaker(s):
-
Adi Frish, Chief Corporate and Business Development
November 15, 2021
08:00 AM ET
Speaker(s):
-
Guy Goldberg, Chief Business Officer
November 22, 2021
02:30 PM CT
Speaker(s):
-
Guy Goldberg, Chief Business Officer
Presentation Details:
Date: Tuesday, November 23, 2021
Time: 14:30 CET
November 30, 2021
08:30 AM EST
December 16, 2021
09:30 AM ET
Speaker(s):
-
Guy Goldberg, Chief Business Officer
January 10, 2022
Speaker(s):
-
Guy Goldberg, Chief Business Officer
Presentation Details:
The presentation will be available on demand from the start of the conference, at 7am ET on Jan 10.
March 17, 2022
08:30 AM EDT
March 29, 2022
Speaker(s):
-
Gilead Raday, Chief Operating Officer
Panel: "Commercialization
of Rare & Ultra Orphan Drugs", taking place on March 30, 2022 at 9:45am ET.
If you have interest in participating in the Cantor Virtual Rare Orphan Disease Summit, please reach out to your Cantor Fitzgerald representative.
May 13, 2022
03:00 PM IDT
May 24, 2022
12:30 PM ET
Fontainebleau Miami Beach Hotel , FL.
Speaker(s):
-
Guy Goldberg, Chief Business Officer
The presentation will be broadcast live and available via replay for 30 days and can be accessed here.
RedHill's Presentation:
Tuesday, May 24, 2022
12:30 p.m. ET
June 23, 2022
08:30 AM ET
July 13, 2022
Boston, MA
Speaker(s):
-
Gina Eagle, Medical Advisor
August 7, 2022
Atlanta, GA
Speaker(s):
-
Mark L. Levitt, Chief Scientific Officer
-
Terry F. Plasse, Medical Director
August 17, 2022
Speaker(s):
-
Kel Sheldon, Associate Director, Medical Affairs
November 21, 2022
Speaker(s):
-
Mark L. Levitt, Chief Scientific Officer
May 31, 2024
Chicago, IL & Online
February 26, 2025
Hilton Zurich Airport Hotel, Switzerland
Chief Business Officer, Guy Goldberg will be presenting on February 27, 2025 at 11:00 am (local time) in room Berne - Track F.